Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

18F-Fluciclovine PET/CT to Identify Patients with Brain Metastasis

Trial Status: active

This phase II trial tests how well 18F-fluciclovine works to identify patients with cancer that has spread to brain (metastasis). 18F-fluciclovine is a radioactive diagnostic agent that is injected into a patient and taken up by tumor cells. The cells can then be visualized using positron emission tomography (PET)/computed tomography (CT) imaging scans. This will assist with identifying tumor cell growth of brain tumor cells, assist in determining treatment, and indirectly overall survival.18F-fluciclovine PET/CT scans may help doctors provide early determination of tumor cell growth of brain tumors to hopefully affect treatment and indirectly overall survival.